Dr Ramón Iglesias-Rey | neuroimaging | Best Researcher Award 
Miguel Servet Researcher at Health Research Institute of Santiago de Compostela (IDIS), Spain 🎓
Dr. Ramón Iglesias Rey is a Miguel Servet Researcher at the Fundación IDIS in Spain. He leads the preclinical Magnetic Resonance Unit within the Neuroimaging and Biotechnology Laboratory. His research focuses on the molecular mechanisms of disease using animal models and bioinstrumentation. He co-founded the spin-off company, LINCbiotech, in 2017.
Professional Profile
🎓 Education
He earned a PhD in Materials Science (2013) and a Physics degree (2006) from the University of Santiago de Compostela.
🏢 Work Experience
Dr. Iglesias has served as a postdoc and research assistant at the University of Santiago and held an international postdoctoral position in Finland (2015).
🧬 Skills
He is skilled in molecular biology, MRI, and bioinstrumentation.
Awards and Honors 🏆
He has multiple patents and co-developed the “Glutamate nanoprobe MR-agent.”
📚 Teaching Experience
Involved in mentoring students in neuroscience and bioengineering.
🔬 Research Focus
📚 Publilcation
- Assessment of Mannitol-Induced Chronic Blood–Brain Barrier Dysfunction In Vivo Using Magnetic Resonance
- Year: 2024
- Journal: International Journal of Molecular Sciences
- Precision Medicine for Blood Glutamate Grabbing in Ischemic Stroke
- Year: 2024
- Journal: International Journal of Molecular Sciences
- C-Reactive Protein, Interleukin-6, and Vascular Recurrence According to Stroke Subtype
- Year: 2024
- Journal: Neurology
- Edoxaban Treatment in a Post-Infarction Experimental Model
- Year: 2024
- Journal: European Journal of Pharmacology
- How Can Radiomics Help the Clinical Management of Patients with Acute Ischemic Stroke?
- Year: 2023
- Journal: Applied Sciences
- Influence of Temperature Chronobiology on Stroke Outcome
- Year: 2023
- Journal: International Journal of Molecular Sciences
- Fibrin-Targeted Nanoparticles for Finding, Visualizing, and Characterizing Blood Clots in Acute Ischemic Stroke
- Year: 2022
- Journal: Pharmaceutics
- Need for a Paradigm Shift in the Treatment of Ischemic Stroke: The Blood-Brain Barrier
- Year: 2022
- Journal: International Journal of Molecular Sciences
- Stress Granules and Acute Ischemic Stroke: Beyond mRNA Translation
- Year: 2022
- Journal: International Journal of Molecular Sciences
- Associations between RNA-Binding Motif Protein 3, Fibroblast Growth Factor 21, and Clinical Outcome in Patients with Stroke
- Year: 2022
- Journal: Journal of Clinical Medicine